Respiratory Syncytial Virus Infection in Adults

ABSTRACT

Respiratory syncytial virus (RSV) is a common wintertime respiratory virus that affects persons of all ages and is the major cause of serious lower respiratory tract infections in young children. However, RSV is also an important pathogen in adults, particularly in the elderly, patients with chronic lung disease, or those with impaired immunity. Clinical features of RSV infections overlap with other respiratory viruses, so laboratory tests are required to establish the diagnosis. Reverse transcriptase polymerase chain reaction (RT-PCR) of samples from nasal swabs, sputum, or bronchoalveolar lavage is a sensitive test to substantiate the diagnosis. Serologies are useful in epidemiological surveys. The clinical course of RSV infections is variable. In infants, RSV presents as bronchiolitis. In adults, mild to moderate upper respiratory tract illness is characteristic. However, severe pneumonia can occur, particularly in the elderly with comorbidities or compromised immune status. Humoral antibodies confer partial immunity to RSV infection and disease severity; cellular immunity is important to eradicate RSV in established infections. Treatment of RSV infections is often supportive. Aerosolized ribavirin is approved for RSV infections in infants; its role in adults is controversial. Infection control measures are critical to limit spread of RSV. Currently, RSV vaccines are not available, but candidate vaccines are being developed.

Respiratory syncytial virus (RSV) - respiratory viruses - lower respiratory tract infection

REFERENCES

• 1 Chanock R, Roizman B, Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA).  Am J Hyg. 1957;  66 281-290
• 2 Dowell S F, Anderson L J, Gary Jr H E et al.. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults.  J Infect Dis. 1996;  174 456-462
• 3 Fleming D M, Cross K W. Respiratory syncytial virus or influenza?.  Lancet. 1993;  342 1507-1510
• 4 Thompson W W, Shay D K, Weintraub E et al.. Mortality associated with influenza and respiratory syncytial virus in the United States.  JAMA. 2003;  289 179-186
• 5 Falsey A R, Hennessey P A, Formica M A, Cox C, Walsh E E. Respiratory syncytial virus infection in elderly and high-risk adults.  N Engl J Med. 2005;  28 1749-1759
• 6 La Montagne J R. RSV pneumonia, a community-acquired infection in adults.  Lancet. 1997;  349 149
• 7 Griffin M, Coffey C S, Neuzil K M, Mitchel E F, Wright P F, Edwards K. Winter viruses: influenza and respiratory syncytial virus-related morbidity in chronic lung disease.  Arch Intern Med. 2002;  162 1229-1236
• 8 Englund J A, Sullivan C J, Jordan M C, Dehner L P, Vercellotti G M, Balfour H H. Respiratory syncytial virus infection in immunocompromised adults.  Ann Intern Med. 1988;  109 203-208
• 9 Mullooly J P, Bridges C B, Thompson W W et al.. Influenza and RSV-associated hospitalizations.  Vaccine. 2007;  25 846-855
• 10 Collins P. The molecular biology of human respiratory syncytial viruses (RSV) of the genus Pneumovirus . In: Kingsbury DW The Paramyxoviruses. Plenum 1991: 103-162
• 11 Walsh E E, Hall C B, Briselli M, Brandriss M W, Schlesinger J J. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection.  J Infect Dis. 1987;  155 1198-1204
• 12 Walsh E E, Schlesinger J J, Brandriss M. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies.  Infect Immun. 1984;  43 756-758
• 13 Johnson P R, Spriggs M K, Olmsted R A, Collins P L. The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins.  Proc Natl Acad Sci USA. 1987;  84 5625-5629
• 14 Johnson P R, Olmsted R A, Prince G A et al.. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity.  J Virol. 1987;  61 3163-3166
• 15 Walsh E E, McConnochie K M, Long C E, Hall C B. Severity of respiratory syncytial virus infection is related to virus strain.  J Infect Dis. 1997;  175 814-820
• 16 Hall C B. Respiratory syncytial virus and parainfluenza virus.  N Engl J Med. 2001;  334 1917-1928
• 17 Hall C B, Walsh E E, Schnabel K C et al.. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children.  J Infect Dis. 1990;  162 1283-1290
• 18 Anderson L J, Hendry R M, Pierik L T, Tsou C, McIntosh K. Multicenter study of strains of respiratory syncytial virus.  J Infect Dis. 1991;  163 687-692
• 19 Agius G, Dindinaud G, Biggar R J et al.. An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings.  J Med Virol. 1990;  30 117-127
• 20 Centers for Disease Control . Epidemiologic notes and reports: respiratory syncytial virus-Missouri.  MMWR. 1977;  26 351
• 21 Garvie D G, Gray J. Outbreak of respiratory syncytial virus infection in the elderly.  BMJ. 1980;  281 1253-1254
• 22 Hart R JC. An outbreak of respiratory syncytial virus infection in an old people's home.  J Infect. 1984;  8 259-261
• 23 Mandal S K, Joglekar V M, Khan A S. An outbreak of respiratory syncytial virus infection in a continuing-care geriatric ward.  Age Ageing. 1985;  14 184-186
• 24 Public Health Laboratory Service Communicable Diseases Surveillance Centre . Respiratory syncytial virus infection in the elderly 1976-1982.  Br Med J (Clin Res Ed). 1983;  287 1618-1619
• 25 Sorvillo F J, Huie S F, Strassburg M A, Butsumyo A, Shandera W X, Fannin S L. An outbreak of respiratory syncytial virus pneumonia in a nursing home for the elderly.  J Infect. 1984;  9 252-256
• 26 Falsey A R, Treanor J J, Betts R F, Walsh E E. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings.  J Am Geriatr Soc. 1992;  40 115-119
• 27 Osterweil D, Norman D. An outbreak of an influenza-like illness in a nursing home.  J Am Geriatr Soc. 1990;  38 659-662
• 28 Hornsleth A, Siggaard-Andersen J, Hjort L. Epidemiology of herpesvirus and respiratory virus infections, I: Serologic findings.  Geriatrics. 1975;  30 61-68
• 29 Arroyo J C, Jordan W, Milligan L. Upper respiratory tract infection and serum antibody responses in nursing home patients.  Am J Infect Control. 1988;  16 152-158
• 30 Mathur U, Bentley D W, Hall C B. Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill.  Ann Intern Med. 1980;  93 49-52
• 31 Morales F, Calder M A, Inglis J M, Murdoch P S, Williamson J. A study of respiratory infection in the elderly to assess the role of respiratory syncytial virus.  J Infect. 1983;  7 236-247
• 32 Gross P A, Rodstein M, LaMontagne J R et al.. Epidemiology of acute respiratory illness during an influenza outbreak in a nursing home.  Arch Intern Med. 1988;  148 559-561
• 33 Nicholson K G, Baker D J, Farquhar A, Hurd D, Kent J, Smith S H. Acute upper respiratory tract viral illness and influenza immunization in homes for the elderly.  Epidemiol Infect. 1990;  105 609-618
• 34 Falsey A R, Walsh E E, Betts R F. Serologic evidence of respiratory syncytial virus infection in nursing home patients.  J Infect Dis. 1990;  162 568-569
• 35 Wald T G, Miller B A, Shult P, Drinka P, Langer L, Gravenstein S. Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons?.  J Am Geriatr Soc. 1995;  43 170-174
• 36 Orr P H, Peeling R W, Fast M et al.. Serological study of responses to selected pathogens causing respiratory tract infection in the institutionalized elderly.  Clin Infect Dis. 1996;  23 1240-1245
• 37 Falsey A R, McCann R M, Hall W J et al.. Acute respiratory tract infection in daycare centers for older persons.  J Am Geriatr Soc. 1995;  43 30-36
• 38 Hall C B, Long C E, Schnabel K C. Respiratory syncytial virus infections in previously healthy working adults.  Clin Infect Dis. 2001;  33 792-796
• 39 Nicholson K G, Kent J, Hammersley V, Esperanza C. Acute viral infections of upper respiratory tract in elderly people living in the community; comparative, prospective, population based study of disease burden.  BMJ. 1997;  315 1060-1064
• 40 Zambon M C, Stockton J D, Clewley J P, Fleming D M. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study.  Lancet. 2001;  358 1410-1416
• 41 Fransen H, Heigl Z, Wolontis S, Forsgren M, Svedmyr A. Infections with viruses in patients hospitalized with acute respiratory illness, Stockholm 1963-1967.  Scand J Infect Dis. 1969;  1 127-136
• 42 Fransen H, Sterner G, Forsgren M et al.. Acute lower respiratory illness in elderly patients with respiratory syncytial virus infection.  Acta Med Scand. 1967;  182 323-329
• 43 Hers J FPh, Masurel N, Gans J C. Acute respiratory disease associated with pulmonary involvement in military servicemen in the Netherlands.  Am Rev Respir Dis. 1969;  100 499-506
• 44 Vikerfors T, Grandien M, Olcen P. Respiratory syncytial virus infections in adults.  Am Rev Respir Dis. 1987;  136 561-564
• 45 Kimball A M, Foy H M, Cooney M K, Allan I D, Matlock M, Plorde J J. Isolation of respiratory syncytial and influenza viruses from the sputum of patients hospitalized with pneumonia.  J Infect Dis. 1983;  147 181-184
• 46 Stanek J, Heinz F. On the epidemiology and etiology of pneumonia in adults.  J Hyg Epidemiol Microbiol Immunol. 1988;  1 31-38
• 47 Zaroukian M H, Leader I. Community-acquired pneumonia and infection with respiratory syncytial virus.  Ann Intern Med. 1988;  109 515-516
• 48 Angeles Marcos M A, Camps M, Pumarola T et al.. The role of viruses in the aetiology of community-acquired pneumonia in adults.  Antivir Ther. 2006;  11 351-359
• 49 Beckham J D, Cadena A, Lin J et al.. Respiratory viral infections in patients with chronic obstructive pulmonary disease.  J Infect. 2005;  50 322-330
• 50 Buscho R O, Saxtan D, Shultz P S, Finch E, Mufson M A. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis.  J Infect Dis. 1978;  137 377-383
• 51 Carilli A P, Gohd R, Gordon W. A virologic study of chronic bronchitis.  N Engl J Med. 1964;  270 123-127
• 52 Fagon J-Y, Chastre J. Severe exacerbations of COPD patients: the role of pulmonary infections.  Semin Respir Infect. 1996;  11 109-118
• 53 Glezen W P, Greenberg S B, Atmar R L, Piedra P A, Couch R B. Impact of respiratory virus infections on persons with chronic underlying conditions.  JAMA. 2000;  283 499-505
• 54 Gump D W, Phillips C A, Forsyth B R. Role of infection in chronic bronchitis.  Am Rev Respir Dis. 1976;  113 465-474
• 55 Lambert H P, Stern H. Infective factors in exacerbations of bronchitis and asthma.  BMJ. 1972;  3 323-327
• 56 Lamy M E, Pouthier-Simon F, Debacker-Willame E. Respiratory viral infections in hospital patients with chronic bronchitis.  Chest. 1973;  63 336-341
• 57 Rohde G, Wiethege A, Borg I et al.. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study.  Thorax. 2003;  58 37-42
• 58 Wiselka M J, Kent J, Cookson J B, Nicholson K G. Impact of respiratory infection in patients with chronic chest disease.  Epidemiol Infect. 1993;  111 337-346
• 59 Walsh E E, Falsey A R, Hennessey P A. Respiratory syncytial virus and other infections in persons with chronic cardiopulmonary disease.  Am J Respir Crit Care Med. 1999;  160 791-795
• 60 Sommerville R G. Respiratory syncytial virus in acute exacerbations of chronic bronchitis.  Lancet. 1963;  II 1247-1248
• 61 Borg I, Rohde G, Loseke S et al.. Evaluation of quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases.  Eur Respir J. 2003;  21 944-951
• 62 Seemungal T AR, Wedzicha J A. Viral infections in obstructive airway diseases.  Curr Opin Pulm Med. 2003;  9 111-116
• 63 Seemungal T, Harper-Owen R, Angshu B et al.. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2001;  164 1618-1623
• 64 Wilkinson T MA, Donaldson G C, Johnston S L, Openshaw P JM, Wedzicha J A. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2006;  173 871-876
• 65 Schwarze J, O'Donnell D R, Rohwedder A, Openshaw P JM. Latency and persistence of respiratory syncytial virus despite T cell immunity.  Am J Respir Crit Care Med. 2004;  169 801-805
• 66 Falsey A R, Formica M A, Hennessey P A, Criddle M, Sullender W M, Walsh E E. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.  Am J Respir Crit Care Med. 2005;  173 639-643
• 67 Falsey A R, Walsh E E. Respiratory syncytial virus infection in adults.  Clin Microbiol Rev. 2000;  13 371-384
• 68 Hudgel D W, Lelan Jr L, Selner J C, McIntosh K. Viral and bacterial infections in adults with chronic asthma.  Am Rev Respir Dis. 1979;  120 393-397
• 69 Beasley R, Coleman E D, Hermon Y, Holst P E, O'Donnell T V, Tobias M. Viral respiratory tract infection and exacerbations of asthma in adult patients.  Thorax. 1988;  43 679-683
• 70 Han L L, Alexander J P, Anderson L J. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden.  J Infect Dis. 1999;  179 25-30
• 71 Gentile D A, Doyle W J, Zeevi A, Piltcher O, Skoner D P. Cytokine gene polymorphisms moderate responses to respiratory syncytial virus in adults.  Hum Immunol. 2003;  64 93-98
• 72 Heinzmann A, Ahlert I, Kurz T, Beiner B, Deichmann K A. Association study suggests opposite effects of polymorphisms with IL8 on bronchial asthma and respiratory syncytial virus bronchiolitis.  J Allergy Clin Immunol. 2004;  114 671-676
• 73 Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families.  Thorax. 2000;  55 1023-1027
• 74 Hull J, Ackerman H, Isles K et al.. Unusual haplotypic structure of IL8, a susceptibility locus for a common respiratory virus.  Am J Hum Genet. 2001;  69 413-419
• 75 Tal G, Madelberg A, Dalal I et al.. Association between common Toll-like rector 4 mutations and severe respiratory syncytial virus disease.  J Infect Dis. 2004;  189 2057-2063
• 76 Lamprecht C L, Krause H E, Mufson M A. Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus.  J Infect Dis. 1976;  134 211-217
• 77 Groothuis J R, Simoes E AF, Levin M J et al.. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children.  N Engl J Med. 1993;  329 1524-1530
• 78 Groothuis J R, Simoes E AF, Hemming V G. Respiratory Syncytial Virus Immune Gobulin Study Group . Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG).  Pediatrics. 1995;  95 463-467
• 79 Sorrentino M, Powers T. Palivizumab Outcomes Study Group . Effectiveness of palivizumab: evaluation of outcomes from the 1998 to 1999 respiratory syncytial virus season.  Pediatr Infect Dis J. 2000;  19 1068-1071
• 80 Hall C B, Walsh E E, Long C E, Schnabel K C. Immunity to and frequency of reinfection with respiratory syncytial virus.  J Infect Dis. 1991;  163 693-698
• 81 Lee FE-H, Walsh E E, Falsey A R, Betts R F, Treanor J J. Experimental infection of humans with A2 respiratory syncytial virus.  Antiviral Res. 2004;  63 191-196
• 82 Walsh E E, Peterson D R, Falsey A R. Risk factors for severe respiratory syncytial virus infection in elderly adults.  J Infect Dis. 2004;  189 233-238
• 83 Walsh E E, Falsey A R. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.  J Infect Dis. 2004;  190 373-378
• 84 Walsh E E, Falsey A R. Age related differences in humoral immune response to respiratory syncytial virus infection in adults.  J Med Virol. 2004;  73 295-299
• 85 Graham B S. Immunologic determinants of RSV-induced disease.  Trends Microbiol. 1996;  4 290-293
• 86 Openshaw P JM. Immunity and immunopathology to respiratory syncytial virus.  Am J Respir Crit Care Med. 1995;  152 S59-S62
• 87 Miller R A. The aging immune system: primer and prospectus.  Science. 1996;  273 70-74
• 88 Abraham G N, Davis M M. Immune System: Functions and Changes Associated with Aging. Bethesda, MD; Report of the Task Force on Immunology and Aging. National Institute of Aging and National Institute of Allergy and Infectious Disease, U.S. Dept. of Health and Human Services 1996. March 15
• 89 Adler W H, Song L, Chopra R. Immune deficiency of aging. In: Powers DC, Morley JE, Coe R Aging, Immunity and Infection. New York, NY; Springer 1994: 66-81
• 90 Pawelec G, Wagner W, Adibzadeh M, Engel A. T cell immunosenescence in vitro and in vivo.  Exp Gerontol. 1999;  34 419-429
• 91 Zhang Y, Wang Y, Gilmore X, Xu K, Wyde P R, Mbawuike I N. An aged mouse model for RSV infection and diminished CD8 + CTL responses.  Exp Biol Med. 2002;  227 133-140
• 92 Looney R J, Falsey A, Walsh E, Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection.  J Infect Dis. 2002;  185 682-685
• 93 Lee F EH, Walsh E E, Falsey A R et al.. The balance between influenza and RSV specific CD4 T cells secreting IL-10 or IFN gamma in young and healthy elderly subjects.  Mech Ageing Dev. 2005;  126 1223-1229
• 94 de Bree G J, Heidema J, van Leewen E MM et al.. Respiratory syncytial virus-specific CD8 + memory T cell responses in elderly persons.  J Infect Dis. 2005;  191 1710-1718
• 95 Johnson K M, Bloom H H, Mufson M A, Chanock R M. Natural infection of adults by respiratory syncytial virus: possible relation to mild upper respiratory disease.  N Engl J Med. 1962;  267 68-72
• 96 Hall W J, Hall C B, Speers D M. Respiratory syncytial virus infection in adults: clinical, virologic, and serial pulmonary function studies.  Ann Intern Med. 1978;  88 203-205
• 97 Shapiro J M, Jean R E. Respiratory syncytial virus.  N Engl J Med. 2001;  345 1132-1133 , (correspondence)
• 98 Walsh E E, Peterson D R, Falsey A R. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly.  J Infect Dis. 2007;  195 1046-1051
• 99 Falsey A R, Cunningham C K, Barker W H et al.. Respiratory syncytial virus and influenza A infections in the hospitalized elderly.  J Infect Dis. 1995;  172 389-394
• 100 Simpson J L, Moric I, Wark P, Johnston L, Gibson P G. Use of induced sputum for the diagnosis of influenza and infections in asthma: a comparison of diagnostic methods.  J Clin Virol. 2003;  26 339-346
• 101 Englund J A, Piedra P, Jewell A, Baxter B B, Whimbey E, Patel K. Rapid diagnosis of respiratory syncytial virus infections in immunocompromised adults.  J Clin Microbiol. 1996;  34 1649-1653
• 102 Falsey A R, McCann R M, Hall W J, Criddle M M. Evaluation of four methods for the diagnosis of respiratory syncytial virus infection in older adults.  J Am Geriatr Soc. 1996;  44 71-73
• 103 Ohm-Smith M J, Nassos P S, Haller B L. Evaluation of the Binax NOW, BD Directigen, and BD Directigen EZ Assays for detection of respiratory syncytial virus.  J Clin Microbiol. 2004;  42 2996-2999
• 104 Casiano-Colon A E, Hulbert B B, Mayer T K, Walsh E E, Falsey A R. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial infection in adults.  J Clin Virol. 2003;  28 169-174
• 105 Borek A P, Clemens S H, Gaskins V K, Aird D Z, Valsamakis A. Respiratory syncytial virus detection by Remel Xpect, Binax NOW RSV, direct immunofluorescent staining, and tissue culture.  J Clin Microbiol. 2006;  44 1105-1107
• 106 Fan J, Henrickson K J, Savatski L L. Rapid simultaneous diagnosis of infections with respiratory syncytial viruses A and B, influenza viruses A and B, and human parainfluenza virus types 1, 2, and 3 by multiplex quantitative reverse transcription-polymerase chain reaction-enzyme hybridization (hexaplex) assay.  Clin Infect Dis. 1998;  26 1397-1402
• 107 Freymuth F, Vabret A, Gourain S et al.. Epidemiology and diagnosis of respiratory syncytial virus in adults.  Rev Mal Respir. 2004;  21 13-14
• 108 Freymuth F, Eugene G, Vabret A et al.. Detection of respiratory syncytial virus by reverse transcription-PCR and hybridization with a DNA enzyme immunoassay.  J Clin Microbiol. 1995;  33 3352-3355
• 109 Falsey A R, Formica M A, Treanor J J, Walsh E E. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding.  J Clin Microbiol. 2003;  41 4160-4165
• 110 Falsey A R, Formica M A, Walsh E E. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness.  J Clin Microbiol. 2002;  40 817-820
• 111 Moore C, Valappil M, Corden S, Westmoreland D. Enhanced clinical utility of the NucliSENS EasyQ RSV A + B assay for rapid detection of respiratory syncytial virus in clinical samples.  Eur J Clin Microbiol Infect Dis. 2006;  25 167-174
• 112 Erdman D D, Anderson L J. Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.  J Clin Microbiol. 1990;  28 2744-2749
• 113 Vikerfors T, Grandien M, Johansson M, Pettersson C-A. Detection of an immunoglobulin M response in the elderly for early diagnosis of respiratory syncytial virus infection.  J Clin Microbiol. 1988;  26 808-811
• 114 Blanco J CG, Boukhvalova M S, Hemming P, Ottolini M, Prince G A. Prospects of antiviral and anti-inflammatory therapy for respiratory syncytial virus infection.  Expert Rev Anti Infect Ther. 2005;  3 945-955
• 115 Hall C B, McBride J T, Walsh E E et al.. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection.  N Engl J Med. 1983;  308 1443-1447
• 116 Committee on Infectious Diseases . Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections.  Pediatrics. 1996;  97 137-140
• 117 Committee on Infectious Diseases . Use of ribavirin in the treatment of respiratory syncytial virus infection.  Pediatrics. 1993;  92 501-504
• 118 Randolph A G, Wang E EL. Ribavirin for respiratory syncytial virus lower respiratory tract infection.  Arch Pediatr Adolesc Med. 1996;  150 942-947
• 119 Feldman R J, Fidalgo H C, John Jr J F. Respiratory syncytial virus in a cardiac surgery intensive care unit.  J Thorac Cardiovasc Surg. 1994;  108 1152
• 120 Takimoto C H, Cram D L, Root R K. Respiratory syncytial virus infections on an adult medical ward.  Arch Intern Med. 1991;  151 706-708
• 121 Liss H P, Bernstein J. Ribavirin aerosol in the elderly.  Chest. 1988;  93 1239-1241
• 122 Englund J A, Piedra P A, Ahn Y-M, Gilbert B E, Hiatt P W. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection.  J Pediatr. 1994;  125 635-641
• 123 Hall C B, Douglas R G, Geiman J M. Respiratory syncytial virus infections in infants: quantitation and duration of shedding.  J Pediatr. 1976;  89 11-15
• 124 Hall C B, Douglas R G. Modes of transmission of respiratory syncytial virus.  J Pediatr. 1981;  99 100-103
• 125 Graman P S, Hall C B. Epidemiology and control of nosocomial viral infections.  Infect Dis Clin North Am. 1989;  3 815-841
• 126 Madge P, Paton J Y, McColl J H, Mackie P LK. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus.  Lancet. 1992;  340 1079-1083
• 127 Falsey A R, Criddle M M, Kolassa J E, McCann R M, Brower C A, Hall W J. Evaluation of a handwashing intervention to reduce respiratory illness rates in senior day-care centers.  Infect Control Hosp Epidemiol. 1999;  20 200-202
• 128 Falsey A R, Walsh E E. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60.  Vaccine. 1996;  14 1214-1218
• 129 Falsey A R, Walsh E E. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly.  Vaccine. 1997;  15 1130-1132
• 130 Gonzalez I M, Karron R A, Eichelberger M et al.. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults.  Vaccine. 2000;  18 1763-1772